Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2009
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/29/2009CA2719936A1 Substituted pyrimidin-5-carboxamides 281
10/28/2009EP2111396A1 Hcv inhibiting macrocyclic phenylcarbamates
10/28/2009EP2111395A1 New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
10/28/2009EP1786779B1 4-arylazo-3,5-diamino-pyrazole compounds and use thereof
10/28/2009EP1633717B1 P2x7 receptor antagonists and their use
10/28/2009EP1631548B1 Inhibitors of akt activity
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009CN101568536A 2-aza-bicyclo[3.1.0]hexane derivatives
10/28/2009CN101568535A Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
10/28/2009CN101568534A Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through GLK
10/28/2009CN101568533A 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors
10/28/2009CN101568527A 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
10/28/2009CN101567425A Organic electroluminescence device, novel platinum complex compound and novel compound capable of being a ligand thereof
10/28/2009CN101565412A Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
10/28/2009CN100554267C Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
10/27/2009US7608711 Reduction with sodium borohydride; lower content of chloroketone and impurity in final product
10/27/2009US7608643 Compounds for inhibiting KSP kinesin activity
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608617 N,N-alkylene-6-(piperidin-1-ylalkoxy)naphthalene-2-carboxamide derivatives, e.g., piperidin-1-yl-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone and 3,4-dihydro-1H-isoquinolin-2-yl)-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone; especially for treating obesity
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009US7608564 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof
10/27/2009US7608563 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same
10/27/2009CA2567935C Aminopyridine derivatives as selective dopamine d3 agonists
10/27/2009CA2536870C Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
10/27/2009CA2506441C 5-substituted-pyrazine or pyridine glucokinase activators
10/27/2009CA2379021C New phenylpiperazines
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009CA2318145C Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
10/22/2009WO2009129211A1 Inhibitors of phosphatidylinositol 3-kinase
10/22/2009WO2009129109A1 Hepatitis c virus inhibitors
10/22/2009WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009WO2009127546A1 Pyrrolidinone glucokinase activators
10/22/2009WO2009104200A8 A method for preparation of thiazolidinedione derivatives
10/22/2009US20090264649 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
10/22/2009US20090264474 Sulfonamides as trpm8 modulators
10/22/2009US20090264459 Organic Compounds
10/22/2009US20090264437 4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
10/22/2009US20090264430 Salt of morpholine compound
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264418 such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-pyrrolidin-1-yl-methanone, useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors
10/22/2009US20090263843 Protein labeling with cyanobenzothiazole conjugates
10/22/2009CA2721434A1 Inhibitors of phosphatidylinositol 3-kinase
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009CA2721203A1 Inhibitors of protein phosphatase-1 and uses thereof
10/22/2009CA2720524A1 Pyrrolidinone glucokinase activators
10/21/2009EP1971601B1 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
10/21/2009EP1708997B1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
10/21/2009EP1426365B9 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
10/21/2009CN101563347A Vasopressin V1a antagonists
10/21/2009CN101560186A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101560158A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
10/21/2009CN100551370C Use of Ranolazine in preparing pharmaceutical composition for treating diabetes
10/20/2009US7605264 Nitrogen-containing tetracylic bridged ring compounds; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
10/20/2009US7605260 Process for producing imide compound
10/20/2009US7605176 β-ketoamide compounds with MCH antagonistic activity
10/20/2009US7605174 Indane derivatives as modulators of ion channels
10/20/2009US7605171 (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
10/20/2009US7605162 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; high affinity for both the dopamine D2 receptor and the serotonin reuptake site; nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia
10/20/2009US7605155 Enzyme inhibitors from pyrazolo[1,5a]pyrimidine as enzyme inhibitors; cyclin dependent kinases (CDKs) inhibitors; cancer, inflammation and arthritis; neurodegenerative diseases such Alzheimer's; cardiovascular, viral and fungal diseases
10/20/2009US7605154 Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
10/20/2009US7605136 Epothilone - saccharide complex; antiproliferative agents; antitumor agents; antiinflammatory agents; central nervous system disorders; multiple sclerosis; Alzheimer's disease; rheumatic disorders; antiarthritic agents
10/20/2009US7605111 Herbicides
10/20/2009US7604874 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2527093C 3-fluoro-piperidines as nmda/nr2b antagonists
10/20/2009CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2009CA2407371C Quinazoline derivatives for the treatment of tumours
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2368993C C7 ester substituted taxanes as antitumor agents
10/20/2009CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/15/2009WO2009126635A1 2-amino-benzothiazole derivates useful as inhibitors of rock kinases
10/15/2009WO2009125873A1 Fused ring compounds and use thereof
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125647A1 Electron donating organic material, material for photovoltaic element, and photovoltaic element
10/15/2009WO2009124968A1 Novel estrogen receptor ligands
10/15/2009WO2009124903A1 Substituted pyridazinylmethyl sulfonamides
10/15/2009WO2009056811A3 Tetrahydrobenzothiazole derivatives with dopamine receptor activity
10/15/2009US20090258907 Compounds useful as inhibitors of rock kinases
10/15/2009US20090258857 Chemical compounds
10/15/2009US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
10/15/2009US20090258851 Diaryl substituted alkanes
10/15/2009US20090258016 Substituted imidazole derivatives
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2720686A1 Fused ring compounds and use thereof
10/14/2009EP1856082B1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
10/14/2009EP1658267B1 Inhibitors of cathepsin s
10/14/2009EP1622897B1 Inhibitors of phosphatidylinositol 3-kinase
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP0941227B2 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
10/14/2009CN101558066A Pyrrole derivatives with antibacterial activity
10/14/2009CN101558058A Modulators of CB1 receptors
10/14/2009CN101555246A Halogen-containing asymmetry phthalocyanines compound, preparation method and application thereof
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 628